EWA
COLL icon

Evolution Wealth Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Evolution Wealth Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-211
Closed -$4K – 255
2021
Q3 		$4K Sell
211
-321
-60% -$6.94K ﹤0.01% 544
2021
Q2 		$13K Hold
532
– – ﹤0.01% 361
2021
Q1 		$13K Sell
532
-178
-25% -$4.23K ﹤0.01% 368
2020
Q4 		$14K Hold
710
– – ﹤0.01% 312
2020
Q3 		$15K Hold
710
– – ﹤0.01% 301
2020
Q2 		$12K Hold
710
– – ﹤0.01% 260
2020
Q1 		$12K Buy
+710
New +$14.7K ﹤0.01% 195

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Evolution Wealth Advisors's COLL Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Collegium Pharmaceutical (COLL) in Q4 2021, closing a stake of 211 shares — an estimated $4K sold.

Evolution Wealth Advisors first reported a position in COLL in Q1 2020 and held it in 7 quarters. The position peaked at $15K in Q3 2020. 159 funds tracked by Wall St. Rank hold COLL as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Collegium Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 211 Collegium Pharmaceutical shares in Q4 2021, an estimated $4K.
  • Evolution Wealth Advisors first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 7 quarters.
  • Evolution Wealth Advisors's Collegium Pharmaceutical position peaked at $15K in Q3 2020.
  • 159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.